Seaport Therapeutics, Inc Common Stock (SPTX) has had the highest return since January 1, 2026 by a US stock in the Biotechnology Industry, returning 213,800%.
| ASSET | % RETURN |
|---|---|
Seaport Therapeutics, Inc Common Stock (SPTX) | 213,800% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 1,008.45% |
GT Biopharma (GTBP) | 795.56% |
Neurosense Therapeutics (NRSN) | 693.75% |
Twist Bioscience (TWST) | 426.28% |
Moderna (MRNA) | 416.39% |
AN2 Therapeutics (ANTX) | 350.89% |
Biodesix (BDSX) | 331.95% |
Immunitybio (IBRX) | 319.8% |
Cue Biopharma (CUE) | 299.42% |
Erasca (ERAS) | 298.11% |
Abcellera Biologics (ABCL) | 269.3% |
Iovance Biotherapeutics (IOVA) | 268.71% |
Climb Bio (CLYM) | 242.68% |
Faeth Therapeutics (FTH) | 233.33% |
Q32 Bio (QTTB) | 219.39% |
Avita Medical (RCEL) | 215.76% |
Veradermics (MANE) | 213.97% |
Oruka Therapeutics (ORKA) | 213.3% |
Rallybio (RLYB) | 211.41% |
First Tracks Biotherapeutics (TRAX) | 205.86% |
Alpha Tau Medical (DRTS) | 204.8% |
Nuvectis Pharma (NVCT) | 186.46% |
CareDx (CDNA) | 185.72% |
Edesa Biotech (EDSA) | 185.52% |